Drug Shortage Report for CIPRO XL

Last updated on 2022-03-02 History
Report ID 97989
Drug Identification Number 02247916
Brand name CIPRO XL
Common or Proper name Ciprofloxacin
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 50's
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-07-06
Actual start date 2020-07-16
Estimated end date
Actual end date 2022-03-01
Shortage status Resolved
Updated date 2022-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2022-03-02 French Compare
v20 2022-03-02 French Compare
v19 2022-03-02 English Compare
v18 2021-11-16 French Compare
v17 2021-11-16 English Compare
v16 2020-07-07 English Compare
v15 2020-06-23 French Compare
v14 2020-06-23 English Compare
v13 2020-06-23 English Compare
v12 2020-06-15 French Compare
v11 2020-06-15 English Compare
v10 2020-06-04 French Compare
v9 2020-06-04 English Compare
v8 2020-06-01 English Compare
v7 2020-04-02 French Compare
v6 2020-04-02 English Compare
v5 2020-02-01 English Compare
v4 2020-01-09 French Compare
v3 2020-01-09 English Compare
v2 2019-11-05 French Compare

Showing 1 to 20 of 21